Mr. Steven Theriault reports

CYTOPHAGE ANNOUNCES RESIGNATION OF DIRECTOR

As disclosed in Cytophage Technologies Ltd.'s management's discussion and analysis for the year ended Dec. 31, 2025, filed on April 30, 2026, Will Ollerhead has resigned as a director of the company, effective April 29, 2026, to focus on other endeavours. The company thanks him for his service and contributions during his tenure as a director, and wishes him continued success in the future.

About Cytophage Technologies Ltd.

Cytophage is a pioneering biotechnology company dedicated to bacteriophage research, product development and commercialization.